Related Experiment Video

Updated: Aug 12, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

The current clinical value of genomic instability

Luis A Diaz1

  • 1Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Avenue, Baustein-Bunting Cancer Research Building, Room 520, Baltimore, MD 21231, USA. ldiaz1@jhmi.edu

Seminars in Cancer Biology
|December 23, 2004
PubMed

Insights

Clinical oncologists overlook genetic instability in cancer. While genetic lesions offer therapeutic targets, their underlying mechanisms

Area of Science:

  • Oncology
  • Genetics
  • Cancer Biology

Background:

  • Genetic instability is a hallmark of human cancers.
  • The clinical implications of genetic instability remain under-explored by oncologists.
  • Genetic lesions in cancer are recognized as valuable diagnostic and therapeutic indicators.

Purpose of the Study:

  • To highlight the ongoing debate surrounding genetic instability in human cancers.
  • To emphasize the clinical utility of genetic lesions as therapeutic targets.
  • To discuss the potential translation of genetic instability mechanisms into clinical practice.

Main Methods:

  • Review of current literature on cancer genetics and clinical oncology.
  • Analysis of the role of genetic lesions in cancer treatment strategies.
  • Discussion of the challenges and opportunities in translating cancer genetics research into clinical applications.

Main Results:

  • Genetic lesions provide significant information for patient treatment.
  • Genetic lesions can be effectively targeted for cancer therapy.
  • The clinical applicability of mechanisms driving genetic lesion accumulation is yet to be determined.

Conclusions:

  • Genetic lesions are crucial for understanding and treating cancer.
  • Exploiting genetic lesions therapeutically shows promise.
  • Further research is needed to translate the understanding of genetic instability mechanisms into clinical benefits for cancer patients.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
In vitro Mutagenesis01:16

In vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...